Simona Carbone, PhD’s Post

🚀 Exciting News! 🚀 We are thrilled to announce our newest product launch on October 11! After a successful human clinical trial, this innovative product is ready to make waves. Are you interested in being one of the first to try it? 🌟 Join our exclusive list now! Learn more about the incredible results here: 🔗 Successful Human Clinical Trial https://lnkd.in/ewMPa_RF Comment below or message me to get on the list! 💬 #ProductLaunch #HealthInnovation #ClinicalTrialSuccess #WellnessRevolution #NewProductAlert #BeTheFirst #LifeChanging #InnovationInHealth #OctoberRelease #Biohacking #WellnessTech #HumanPotential

Driving meaningful innovative change across research & development to ensure a better understanding and predictability of safety events! A long term dream of mine. Enabling Translational Safety through collaboration. Co-Leading sustainability efforts across the ecosystem to enable high quatity product lifecycle management, efficiency and acceleration of medicines developmets.

Today, on #Juneteenth, we don't just celebrate liberation – we ignite it. At Molekule Consulting LLC, we channel the unyielding spirit of those who fought for freedom into our relentless pursuit of groundbreaking biopharma solutions. Just as the echoes of Juneteenth reverberate through history, our impact echoes through the lives transformed by the medicines we help bring to the world. We shatter barriers, defy limitations, and rewrite the rules of what's possible in healthcare. But our work is far from finished. The struggle for health equity is a marathon, not a sprint. We stand shoulder-to-shoulder with those who continue to fight for a world where every life is valued, every voice is heard, and every person has the opportunity to thrive. On this Juneteenth, we don't just honor the past – we forge the future. Join us as we revolutionize healthcare, empower communities, and create a legacy of progress that burns as brightly as the Juneteenth sun. #DiversityInBiopharma #Innovation #Pharma #HealthEquity

Chapter One. To me, that is what January represents – the beginning of a new story that we all get to write together. As we kickstart the new year, I’m excited to begin the first chapter of what promises to be a yearlong story of people coming together to help our patients and their loved ones lead happier, healthier lives; Of innovation that pushes the boundaries of science; Of teams dedicated to bringing that science to the patients who need it most; Of all of us, collectively, working to uplift each other, our industry and our society at large. At Novartis US, the stories we write would not be possible without our teams who bring them to life – a dedicated group of colleagues working tirelessly to magnify our impact in a meaningful and significant manner, in service of our patients. As we look ahead to where we can make a difference, let’s also be mindful of the platform we have to create opportunities for others who will carry our stories forward. Using our seat at the table to set the table for others – that is how our stories build and grow. What stories will you bring to life this year? Share in the comments below ⤵️ #Novartis #ReimagineMedicine

We're only 8 Weeks away 😲 You're invited to dive headfirst into the future of healthcare at #DTxWest, where the buzz isn't just about digital therapeutics, but about transforming health with innovation and expertise! Lock in your calendar for February 21st - 23rd because something revolutionary is coming to Hollywood! 🌅 Why You Should Join? 🤔 Imagine this: You, surrounded by the brightest minds in digital health, exploring the forefront of therapeutic innovation, and gaining insights that could change the game. Sounds like a plan, right? Early Birds Catch the Worms (and Savings)! 🐦 We hate to break it to you, but time's ticking! Our early-bird offer ends on January 26th. Act fast and secure your spot to save big while securing a front-row seat. Register here: www.dtxwest.com/register Check Out Some of Our DTxperts Taking the Stage... Adam Haim of National Institute of Mental Health (NIMH), Yuma Nishikawa of DG Daiwa Ventures - GP of DG Lab Fund, Timothy L. of Highmark Inc., Ramita Tandon of Walgreens Boots Alliance, Doug Lee of Bayer, Julie Fishman of Astellas Pharma US, Gautam M Shah of Carelon Elevance Health, Kathryn Drzewiecki of FDA. Ready to step into the future of healthcare? Don't delay; secure your spot now and let's redefine what's possible together: www.dtxwest.com/register #dtx #digitaltherapeutics #digitalhealth

✨ Exciting News: Our Q4 2023 Investor Updates are Here! ✨ As we close another successful quarter, we're thrilled to share the significant milestones we've achieved in Q4 2023. 🚀 - We have progressed in our 750K seed round, and still interested in other investment opportunities 📲 - We have filed our patent and trademarks 🗂️ - Advanced towards FDA approval ✅ These milestones represent our commitment to PragmaClin’s mission to be a global leader in managing neurological disorders! Our journey doesn't stop here, we’re already gearing up for an even more exciting Q1 2024, with clinical trials underway. 📈 Email contact@pragmaclin.com to join our Investor Update list and stay up to date about our exciting journey. 📥 A huge thank you to our dedicated team, supportive investors, loyal advisors and KOLs. Here's to continuing our success together! #InvestorUpdate #Q4Results #FinancialPerformance #InvestmentOpportunities #MarketTrends #BusinessGrowth #QuarterlyReport

🧬 Want to accelerate your therapy’s journey from lab to clinic? At Advanced Therapies Week 2025, we’re deep diving into the most pressing challenges in advanced therapies: 🔑 Navigating complex regulatory pathways with updated insights 🔑 Securing funding and partnerships to take your novel therapies to market 🔑 Sharing clinical trial success stories that highlight how you can scale your innovations Whether it’s finding the right collaborators or maintaining your competitive edge, the agenda is packed with content to drive your business forward. 🎟️ Don’t wait—lock in the Super Early Bird rate before October 4th! https://ow.ly/P5QZ50Tu76e #ATW25 #RegulatoryUpdates #ClinicalTrials #PartneringOpportunities #AdvancedTherapiesWeek

It's hard to believe it's been over a month since we co-hosted the 2024 #BLUEKNIGHT Symposium with the Biomedical Advanced Research and Development Authority (BARDA)! The day was full of inspiring founder stories, lively conversations, and important insights from global thought leaders. If you missed it (or want to experience it again), we're excited to our a recap and the on-demand content: https://jji.jnj/3WyOrn4    Here's a sneak preview of some of the key takeaways including:  1. The importance of building relationships: While networking isn’t new, it's always importance to hear the perspectives of funders, regulatory advisors, and entrepreneurs and how building an extensive stakeholder engagement plan has helped them along their journeys.  2. Celebrating scientific advancements: It’s inspiring to hear directly from BLUE KNIGHT™ companies and this year’s symposium offered several opportunities to engage with founders, including a company showcase, poster session, and a special awardee announcement of our most recent BLUE KNIGHT™ Resident QuickFire Challenge: Partnering for Preparedness.  3. Looking ahead to the future: It was great to hear from colleagues at Johnson & Johnson and BARDA highlight the areas of future interest for BLUE KNIGHT™. From multi-use applications that can pivot rapidly to solutions that enable equitable access, we’re eager to engage with start-ups that are developing sustainable preparedness solutions. Be sure to check out the on-demand recordings and reflections from Ashim Subedee and me in this blog with takeaways: https://jji.jnj/3WyOrn4

At Astellas, we recognise that how we show up to work and behave is intrinsically linked to our ambition to turn innovative science into value for patients. The first of five principles helping us amplify our impact for the benefit of patients is ‘outcome focus over task orientation’. It is all too easy to lose yourself in your daily ‘to-do’ list at the expense of achieving the goals that really matter. Listen to the clip to find out why, with stakes this high, we are actively guarding against it, ready to course correct at a moment’s notice.

''You got the invitation You got the right address, You need some medication? The answer's always "Yes." A little chance encounter Could be the one you've waited for; Just squeeze a bit more Tonight we're on a mission Tonight's the casting call. If this is the real audition, Oh, God, help us all. You make the right impression, Then ev'rybody knows your name. We're in the fast lane. Someone in the crowd could be the one you need to know, The one to finally lift you off the ground. Someone in the crowd could take you where you wanna go, If you're the someone ready to be found, You're the someone ready to be found. Do what you need to do, 'Til they discover you, And make you more than who You're seeing now. So with the stars aligned, I think I'll stay behind. You've got to go and find That someone in the crowd. Is someone in the crowd the only thing you really see? Watching while the world keeps spinning 'round? Somewhere there's a place where I find who I'm gonna be, A somewhere that's just waiting to be found. Someone in the crowd could be the one you need to know, The someone who could lift you off the ground. Someone in the crowd could take you where you wanna go, Someone in the crowd could make you Flying off the ground, If you're the someone ready to be found....'''' - ''Someone In the Crowd'' - Justin Hurwitz et al, ''La La Land.'' Who might be the #someone in the crowd you meet at the Founder's Forum? Planning is underway and for the Founder's Forum, a small event of only 200 people where #funders meet founders of psychedelics & Cannabis companies. Held in San Diego, one of the #wealthiest places in the world, and a key wellness and biotech hub in the USA, the event is unique to the industry. PE Groups, SEC accredited investors, as well as #FamilyOffices located in San Diego, and beyond are being invited to attend. Follow the page for more updates: The Founder's Forum—where funders meet founders in #psychedelics and #Cannabis